Health Ministry approves introduction of new shorter, more efficacious treatment regimen for ...
Health Ministry approves BPaLM regimen, a shorter, more effective treatment for MDR-TB, consisting of Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin, curing drug-resistant TB in six months with high success rates and cost savings.
Reference News
India Introduces Groundbreaking Shorter Treatment for Drug-Resistant TB under National ...
India's Health Ministry approves BPaLM regimen for MDR-TB, offering a 6-month treatment with higher success rates, aligning with the goal to eliminate TB by 2025.
Health Ministry approves introduction of new shorter, more efficacious treatment regimen for ...
Health Ministry approves BPaLM regimen, a shorter, more effective treatment for MDR-TB, consisting of Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin, curing drug-resistant TB in six months with high success rates and cost savings.